Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($0.76), $0.18 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $14.64 million versus the consensus estimate of $10.94 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.